Multiple therapies for vaginal bleeding secondary to large uterine myomas.
Acute vaginal bleeding secondary to uterine myomas can be a devastating event. We report the use of a combined therapeutic approach in a patient who presented with protracted bleeding of a myomatous uterus that was equivalent in size to a 38 week gestation. This patient's course was further complicated by her refusal of blood or blood products.
Thomas
M A
MA
Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Ohio.
Gass
M L
ML
Scott
M C
MC
Liu
J H
JH
D000208:Acute Disease; D000328:Adult; D000740:Anemia / Q000209:etiology; D003131:Combined Modality Therapy; D003280:Contraceptives, Oral, Synthetic / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use*; D005260:Female; D006400:Hematocrit; D006801:Humans; D007279:Injections, Subcutaneous; D007889:Leiomyoma / Q000150:complications*; D016729:Leuprolide / Q000008:administration & dosage / Q000627:therapeutic use*; D011300:Preoperative Care / Q000379:methods; D013630:Tampons, Surgical; D013997:Time Factors; D016312:Treatment Refusal; D014592:Uterine Hemorrhage / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D014594:Uterine Neoplasms / Q000150:complications*
D003280:Contraceptives, Oral, Synthetic; D004966:Estrogens, Conjugated (USP); D016729:Leuprolide